Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Value of the Combination Ultrasonography With Ti-RADS Score / Dual Tracer Scintigraphy MIBI-Tc99m/Iodine-123 in the Detection of Malignancy of Thyroid Nodules (Sup or Egal to 15 mm) Classified Bethesda III or IV on Cytology

NCT03498183 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT03498183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03498183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Value of the Combination Ultrasonography With Ti-RADS Score / Dual Tracer Scintigraphy MIBI-Tc99m/Iodine-123 in the Detection of Malignancy of Thyroid Nodules (Sup or Egal to 15 mm) Classified Bethesda III or IV on Cytology
Lead sponsor
Nantes University Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
January 17, 2019
Completion date
May 7, 2025
Enrollment
372 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

malignancy of thyroid nodules